Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotypes and phenotypes: should genetic markers and clinical predictors drive initial treatment decisions in rheumatic diseases?

Current opinion in rheumatology - 1 May 2003

Scott David L

Abstract excerpt

Using patients' genetic and phenotypic profiles to identify the best available drug therapy for individual cases remains a clinical aspiration. Considerable recent research has developed this theme in rheumatoid arthritis (RA). Seven reports have evaluated how the high-risk epitope and other genes influence RA susceptibility and severity. There is strong evidence that the shared epitope influences susceptibility,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antirheumatic Agents
Share to Clinical Trials as Topic
Share to Decision Making

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Predictive Value of Tests

Share to Rheumatic Diseases

Share to Rheumatoid Factor

Share to Risk Assessment

Share to Severity of Illness Index

Source

Identifiers

PMID: 12707573
DOI: 10.1097/00002281-200305000-00007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotypes and phenotypes: should genetic markers and clinical predictors drive initial treatment decisions in rheumatic diseases?PMID 12707573Read ↗

The genetic architecture of rheumatoid arthritis: from susceptibility to clinical subphenotype associations.Semantic proximity Read ↗

Genetic influences modulating the radiological severity of rheumatoid arthritis.Semantic proximity Read ↗

Genetic data: The new challenge of personalized medicine, insights for rheumatoid arthritis patients.Semantic proximity Read ↗

Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients.Semantic proximity Read ↗

Genetic risk score predicting risk of rheumatoid arthritis phenotypes and age of symptom onset.Semantic proximity Read ↗

A weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis risk.Semantic proximity Read ↗

The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register.Semantic proximity Read ↗

Do Genetic Susceptibility Variants Associate with Disease Severity in Early Active Rheumatoid Arthritis?Semantic proximity Read ↗

Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and PharmacogeneticsSemantic proximity Read ↗

HLA-DR risk variants in rheumatoid arthritis: what we know and still do not know.Semantic proximity Read ↗

Rheumatoid arthritis. Evidence for a genetic component to disease severity in RA.Semantic proximity Read ↗

Pharmacogenetics in treatment of rheumatoid arthritis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.